ACPP: A Web Server for Prediction and Design of Anti-cancer Peptides
- 656 Downloads
Cancer is one of the most common diseases, which causes more mortality worldwide. Despite the presence of several therapies against cancer, peptides as therapeutic agents are gaining importance. Experimental studies report that peptides containing apoptotic domain exhibit anticancer activity. Hence in this study, we propose a computational method using support vector machine and protein relatedness measure feature vector, in which provision was made to assess the query protein for the presence of any apoptotic domains or not and then to scan/predict the anti-cancer peptides in the protein. Different datasets, including newly developed positive and negative dataset, AntiCP dataset, and balanced randomly generated peptides were used to validate the proposed method. The validation results on independent dataset suggested (sensitivity = 0.95; specificity = 0.97; MCC = 0.92; and Accuracy = 0.96) that the proposed method outperformed the existing method in predicting anti-cancer peptides. The user friendly webserver includes three different modes (i) Protein scan with apoptotic domain prediction; (ii) Multiple peptide mode; and (iii) Peptide mutation mode for prediction and design of anti-cancer peptides. The server was developed using PERL CGI and freely accessible at http://acpp.bicpu.edu.in/predict.php. The established tool will be useful in investigating and designing potent anti-cancer peptides from the query protein effectively.
KeywordsAnti-cancer peptides Cancer Apoptotic domain prediction SVM Protein relatedness Measure ACPP
Saravanan Vijayakumar is supported by the DBT-BINC, senior research fellow. The authors thank Centre for Bioinformatics for providing necessary computational facility and Dr. Archana Pan (Centre for Bioinformatics, Pondicherry University) and Dr. Sivasathya (Department of Computer Science, Ponidcherry University) for their valuable suggestions.
Compliance with Ethics Guildlines
Conflict of interest
Saravanan Vijayakumar and PTV. Lakshmi declares that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
- Chang C-C, Lin C-J (2011) LIBSVM: a library for support vector machines. ACM Transactions on Intelligent Systems and Technology (TIST) 2:27Google Scholar
- Cortes C, Vapnik V (1995) Support vector machine. Machine learning 20:273–297Google Scholar
- El-Manzalawy Y, Honavar V (2005) WLSVM: Integrating libsvm into WEKA environment. Software available at http://www.csiastateedu/yasser/wlsvm. Accessed 14 Jan 2012
- Freund Y, Schapire R, Abe N (1999) A short introduction to boosting. J Jpn Soc Artif Intell 14:1612Google Scholar
- Gautam A, Singh H, Tyagi A, Chaudhary K, Kumar R, Kapoor P, Raghava G (2012) CPPsite: a curated database of cell penetrating peptides. Database 2012:bas015Google Scholar
- Kakde D, Jain D, Shrivastava V, Kakde R, Patil A (2011) Cancer therapeutics-opportunities, challenges and advances in drug delivery. J Appl Pharm Sci 1:1–10Google Scholar
- Mendoza FJ, Espino PS, Cann KL, Bristow N, McCrea K, Los MJ (2005) Anti-tumor chemotherapy utilizing peptide-based approaches-apoptotic pathways, kinases, and proteasome as targets. Arch Immunol Ther Exp 53:47–60Google Scholar
- Mehta D et al (2014) ParaPep: a web resource for experimentally validated antiparasitic peptide sequences and their structures. Database 2014:bau051Google Scholar
- Uppada SB, Erickson T, Wojdyla L, Moravec DN, Song Z, Cheng J, Puri N (2014) Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy. Int J Nanomed 9:43Google Scholar
- Zhang H, Gu C (2008) Support vector machines versus Boosting. Electrical Engineering UC, BerkeleyGoogle Scholar